Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04551599 · ClinicalTrials.gov registry record · Phase 1
A Study of the Effects of Food and Age on Danicopan
A Phase 1 study, sponsored by Alexion Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT04551599 is a Phase 1 study that has completed, run by Alexion Pharmaceuticals. The registered enrollment target is 27 participants.
The verdict
NCT04551599, a Phase 1 study, has completed, sponsored by Alexion Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
This will be an open-label, 2-part study. Part 1 will be a randomized, 2-sequence, 2-period crossover, food-effect study in healthy young adult participants. Part 2 will be a 1-period age-effect study in healthy elderly male participants.
Interventions
- DRUG Danicopan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2020-02-21 |
| Est. Completion | 2021-02-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04551599
The ClinicalTrials.gov registry entry for NCT04551599 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alexion Pharmaceuticals, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Danicopan is the first listed.
NCT04551599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04551599 about?
NCT04551599 is a clinical study titled "A Study of the Effects of Food and Age on Danicopan". This will be an open-label, 2-part study. Part 1 will be a randomized, 2-sequence, 2-period crossover, food-effect study in healthy young adult participants. Part 2 will be a 1-period age-effect study in healthy elderly male participants.
What is the current status of trial NCT04551599?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2020-02-21. Estimated completion is 2021-02-03.
What interventions are being tested in trial NCT04551599?
The interventions under investigation include: Danicopan (DRUG).
Who is sponsoring clinical trial NCT04551599?
This trial is sponsored by Alexion Pharmaceuticals, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.